# Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension

> **NCT00942708** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 6 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Fluoxetine

## Key facts

- **NCT ID:** NCT00942708
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-06
- **Final completion:** 2011-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942708, "Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00942708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*